Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

[Metformin, renal function and lactate: the MetClear Study].

Mitrov-Winkelmolen L, Oude Engberink RD, Roelofs R, Ponjee GA, Vleming LJ, Wilms EB, Geelhoed-Duijvestijn NH.

Ned Tijdschr Geneeskd. 2014;158(5):A6266. Dutch.

PMID:
24472334
2.

Nurse practitioner care improves renal outcome in patients with CKD.

Peeters MJ, van Zuilen AD, van den Brand JA, Bots ML, van Buren M, Ten Dam MA, Kaasjager KA, Ligtenberg G, Sijpkens YW, Sluiter HE, van de Ven PJ, Vervoort G, Vleming LJ, Blankestijn PJ, Wetzels JF.

J Am Soc Nephrol. 2014 Feb;25(2):390-8. doi: 10.1681/ASN.2012121222. Epub 2013 Oct 24.

3.

Validation of the kidney failure risk equation in European CKD patients.

Peeters MJ, van Zuilen AD, van den Brand JA, Bots ML, Blankestijn PJ, Wetzels JF; MASTERPLAN Study Group.

Nephrol Dial Transplant. 2013 Jul;28(7):1773-9. doi: 10.1093/ndt/gft063. Epub 2013 May 3.

PMID:
23645476
4.

Multifactorial intervention with nurse practitioners does not change cardiovascular outcomes in patients with chronic kidney disease.

van Zuilen AD, Bots ML, Dulger A, van der Tweel I, van Buren M, Ten Dam MA, Kaasjager KA, Ligtenberg G, Sijpkens YW, Sluiter HE, van de Ven PJ, Vervoort G, Vleming LJ, Blankestijn PJ, Wetzels JF.

Kidney Int. 2012 Sep;82(6):710-7. doi: 10.1038/ki.2012.137. Epub 2012 Jun 27.

PMID:
22739979
5.

Quality of care in patients with chronic kidney disease is determined by hospital specific factors.

van Zuilen AD, Blankestijn PJ, van Buren M, ten Dam MA, Kaasjager KA, Ligtenberg G, Sijpkens YW, Sluiter HE, van de Ven PJ, Vervoort G, Vleming LJ, Bots ML, Wetzels JF; MASTERPLAN Study Group.

Nephrol Dial Transplant. 2010 Nov;25(11):3647-54. doi: 10.1093/ndt/gfq184. Epub 2010 Apr 9.

6.

ACTH-producing pheochromocytoma: clinical considerations and concise review of the literature.

Nijhoff MF, Dekkers OM, Vleming LJ, Smit JW, Romijn JA, Pereira AM.

Eur J Intern Med. 2009 Nov;20(7):682-5. doi: 10.1016/j.ejim.2009.08.002. Epub 2009 Aug 31. Review.

PMID:
19818286
7.

Renal failure due to acute phosphate nephropathy.

Slee TM, Vleming LJ, Valentijn RM.

Neth J Med. 2008 Nov;66(10):438-41.

8.

GMP-17-positive T-lymphocytes in renal tubules predict progression in early stages of IgA nephropathy.

van Es LA, de Heer E, Vleming LJ, van der Wal A, Mallat M, Bajema I, Bruijn JA, de Fijter JW.

Kidney Int. 2008 Jun;73(12):1426-33. doi: 10.1038/ki.2008.66. Epub 2008 Mar 19.

PMID:
18354379
9.

N-acetylcysteine and hemodialysis treatment of a severe case of methyl ethyl ketone peroxide intoxication.

van Enckevort CC, Touw DJ, Vleming LJ.

Clin Toxicol (Phila). 2008 Jan;46(1):74-8. doi: 10.1080/15563650701232414.

PMID:
18167039
10.

[Optimisation of the antibiotic policy in the Netherlands. X. The SWAB guideline for antimicrobial treatment of complicated urinary tract infections].

Geerlings SE, van den Broek PJ, van Haarst EP, Vleming LJ, van Haaren KM, Janknegt R, Platenkamp GJ, Prins JM.

Ned Tijdschr Geneeskd. 2006 Oct 28;150(43):2370-6. Review. Dutch.

PMID:
17100128
11.

Multifactorial approach and superior treatment efficacy in renal patients with the aid of nurse practitioners. Design of The MASTERPLAN Study [ISRCTN73187232].

van Zuilen AD, van der Tweel I, Blankestijn PJ, Bots ML, van Buren M, ten Dam MA, Kaasjager KA, van de Ven PJ, Vervoort G, Vleming LJ, Ligtenberg G, Wetzels JF; MASTERPLAN study group.

Trials. 2006 Mar 30;7:8.

12.

Rationale and design of the MASTERPLAN study: Multifactorial approach and superior treatment efficacy in renal patients with the aid of nurse practitioners.

Van Zuilen AD, Wetzels JF, Blankestijn PJ, Bots ML, Van Buren M, Ten Dam MA, Kaasjager KA, Van De Ven PJ, Vleming LJ, Ligtenberg G, Ligtenberg G; MASTERPLAN Study Group.

J Nephrol. 2005 Jan-Feb;18(1):30-4.

PMID:
15772920
13.

A case of minimal change disease evolving into steroid-dependent nephrotic syndrome with hematuria.

Jonkers IJ, Bruijn JA, Vleming LJ.

Am J Kidney Dis. 2004 Oct;44(4):773-7. No abstract available.

PMID:
15384031
14.

ARF and cerebral infarcts in a young woman.

Aydin Z, Bruijn JA, Vleming LJ.

Am J Kidney Dis. 2004 Jul;44(1):179-83. No abstract available.

PMID:
15211451
15.

Distribution of fibronectin isoforms in human renal disease.

Van Vliet A, Baelde HJ, Vleming LJ, de Heer E, Bruijn JA.

J Pathol. 2001 Feb;193(2):256-62.

PMID:
11180174
16.

The pathogenesis of progressive renal failure.

Vleming LJ, Bruijn JA, van Es LA.

Neth J Med. 1999 Mar;54(3):114-28. Review.

PMID:
10189786
17.

The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM.

Vleming LJ, van der Pijl JW, Lemkes HH, Westendorp RG, Maassen JA, Daha MR, van Es LA, van Kooten C.

Clin Nephrol. 1999 Mar;51(3):133-40.

PMID:
10099885
18.

Histomorphometric correlates of renal failure in IgA nephropathy.

Vleming LJ, de Fijter JW, Westendorp RG, Daha MR, Bruijn JA, van Es LA.

Clin Nephrol. 1998 Jun;49(6):337-44.

PMID:
9696428
19.

The glomerular deposition of PAS positive material correlates with renal function in human kidney diseases.

Vleming LJ, Baelde JJ, Westendorp RG, Daha MR, van Es LA, Bruijn JA.

Clin Nephrol. 1997 Mar;47(3):158-67.

PMID:
9105762
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk